Company / Profit Margin
Avalo Therapeutics, Inc. Profit Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-132642.4%
FY2025
5-year range
-132642.4% / -230.8%
FY2021-FY2025
Trend
-1565.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -1565% YoY in FY2025, a notable deviation from the 8-year average annual change of -527%.
Based on SEC 10-K filings.
-132642.4% in FY2025 with a 5-year CAGR of -131694.5%.
Declined from -1639.5% to -132642.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -132411.6pp
- 5-Year Change
- -131694.5pp
- 10-Year Change
- -
Key checks
Key Insights
- Avalo Therapeutics, Inc.'s profit margin has declined for 3 consecutive years.
- In FY2025, profit margin decreased 1565.2% year-over-year.
- Peak profit margin was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -132642.4% | -1565.2% |
| FY2024 | -7965.8% | -385.9% |
| FY2023 | -1639.5% | -610.4% |
| FY2022 | -230.8% | +85.2% |
| FY2021 | -1563.1% | -64.9% |
| FY2020 | -947.9% | -298.1% |
| FY2019 | -238.1% | +58.2% |
| FY2018 | -569.9% | -1435.2% |
| FY2017 | 42.7% | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026